Cargando…
Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation
BACKGROUND: Previous cost-effectiveness studies of cholinesterase inhibitors have modeled Alzheimer's disease (AD) progression and treatment effects through single or global severity measures, or progression to "Full Time Care". This analysis evaluates the cost-effectiveness of donepe...
Autores principales: | Hartz, Susanne, Getsios, Denis, Tao, Sunning, Blume, Steve, Maclaine, Grant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296601/ https://www.ncbi.nlm.nih.gov/pubmed/22316501 http://dx.doi.org/10.1186/1471-2377-12-2 |
Ejemplares similares
-
Florbetaben PET in the Early Diagnosis of Alzheimer's Disease: A Discrete Event Simulation to Explore Its Potential Value and Key Data Gaps
por: Guo, Shien, et al.
Publicado: (2012) -
Expected lifetime numbers and costs of fractures in postmenopausal women with and without osteoporosis in Germany: a discrete event simulation model
por: Bleibler, Florian, et al.
Publicado: (2014) -
Transdermal donepezil on the treatment of Alzheimer’s disease
por: Sozio, Piera, et al.
Publicado: (2012) -
Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial)
por: Knapp, Martin, et al.
Publicado: (2016) -
Discrete-event system simulation
por: Banks, Jerry, et al.
Publicado: (2010)